welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Study identifies enhanced impact of treatment for hereditary cancer patients
People with an inherited syndrome called familial adenomatous polyposis (FAP) have a 100% lifetime risk of developing colorectal cancer if they do not seek appropriate medical care. Recent findings published by researchers at Huntsman Cancer Institute at the University of Utah identified a promising prevention treatment for patients with FAP. A new study takes these findings a step further by reporting that the treatment led to a near-complete blockade of cancer growth pathways in polyps isolated from FAP patients. Further, these patients showed evidence of activated immune responses aimed at destroying pre-cancerous polyps. The findings were published today in the journal Cancer Prevention Research.

expertly curated content related to this topic
-
Bonnies Diary April 08https://jtvcancersupport.com/embed/46253...
-
Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Pati...This is a registry-based observation...
-
Management of Duodenal Adenomatosis in FAP: Single Centre ExperienceDuodenal and ampullary carcinoma in fami...
-
Role of Surgery in Familial Adenomatous Polyposis and Hereditary Non Polyposis Colorectal Cancer (Lynch Syndrome)Surgery remains the mainstay of treatmen...
-
The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized C...Familial adenomatous polyposis (FAP) lea...
-
Sulindac Sulfone Induced Regression of Rectal Polyps in Patients with Familial Adenomatous PolyposisSulindac sulfone (Exisulind), a metaboli...
-
Chemoprevention of Familial Adenomatous PolyposisFamilial adenomatous polyposis (FAP) has...